Error: Could not add to watchlist. X

Genmab A/S

+ Watchlist
GE9:GR
Frankfurt
87.17
EUR
0.76
0.88%
As of 13:35:39 ET on 08/03/2015.
Open
85.29
Day Range
85.28 - 87.86
Volume
70
Previous Close
86.41
52Wk Range
28.65 - 92.75
1 Yr Return
194.68%
Open
85.29
Day Range
85.28 - 87.86
Volume
70
Previous Close
86.41
52Wk Range
28.65 - 92.75
1 Yr Return
194.68%
YTD Return
79.60%
Current P/E Ratio (TTM)
-
Earnings per Share (DKK) (TTM)
-
Market Cap (b EUR)
5.118
Shares Outstanding (m)
58.718
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Genmab A/S is a biotechnology company. The Company creates and develops human antibody products for the treatment of life threatening and debilitating diseases. Genmab focuses on products to treat cancer, rheumatoid arthritis and other inflammatory conditions, and psoriasis. The Company develops new products through partnerships. Genmab operates in Europe and the United States.
ADDRESS
Bredgade 34
Copenhagen K, 1260
Denmark
PHONE
45-70-20-27-28
  • Jan G J Van De Winkel
    President/CEO/Co-Founder
  • David A Eatwell
    Exec VP/CFO
  • Paul W H I Parren
    Senior VP/Dir:Scientific
  • Michael K Bauer
    Senior VP:Clinical Development
  • Anthony Pagano
    Senior VP:Global Finance
Show More